J Cerebrovasc Endovasc Neurosurg > Volume 25(2); 2023 > Article |
|
Variables | Adjusted OR | 95% CI | p-value |
---|---|---|---|
(Intercept) | 0.00 | 0 - Inf | 0.9998 |
Gender† | 2.83 | NA - Inf | 1.0000 |
AgeOp†† | 12.48 | 0 - 2.502315e+66 | 0.9985 |
SubGroup 1††† | 0 | NA - Inf | 0.9999 |
SubGroup 2††† | 0 | 0 - Inf | 1.0000 |
DAPTG 6†††† | 0 | 0 - Inf | 0.9998 |
DAPTG 9†††† | 0 | NA - Inf | 0.9999 |
DAPTG 12†††† | 222.97 | 0 - Inf | 1.0000 |
DAPTG 13†††† | 0 | 0 - Inf | 0.9998 |
Diabetes | 2.15 | 0 - Inf | 1.0000 |
Hypertension | 0 | 0 - Inf | 0.9998 |
Cardiovascular disease | 0 | NA - Inf | 0.9999 |
Aspirin | 0.03 | 0 - Inf | 1.0000 |
Other antiplatelets | 0 | 0 - Inf | 0.9998 |
Anticoagulants | 0 | 0 - Inf | 1.0000 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) | 0 | 0 - Inf | 0.9999 |
Aspirin as analgesics | 7.35 | 0 - Inf | 0.9999 |
Steroids | 0 | 0 - Inf | 0.9997 |
Selective serotonin reuptake inhibitors (SSRI) | 0 | 0 - Inf | 0.9999 |
Proton pump inhibitors (PPI) | 0 | 0 - Inf | 0.9995 |
HMG-CoA inhibitors (statins) | 6.34 | 0 - Inf | 0.9994 |
Variables | Adjusted OR | 95% CI | p-value |
---|---|---|---|
(Intercept) | 3.649383e+06 | 0.00 - 4.410196e+298 | 0.9989 |
Gender† | 5.55 | 0.03 - 5.986921e+04 | 0.5902 |
AgeOp†† | 0.98 | 0.82 - 1.13 | 0.7643 |
SubGroup 1††† | 7.379513e+10 | 0 - Inf | 0.9989 |
SubGroup 2††† | 230.78 | 0 - Inf | 0.9999 |
DAPTG 6†††† | 19.82 | 0.50 - 5050.15 | 0.1653 |
DAPTG 9†††† | 0 | 0.00 - 1.589189e+189 | 0.9988 |
DAPTG 12†††† | 0 | 0 - Inf | 0.9990 |
DAPTG 13†††† | 273 | 3.35 - 2.300476e+05 | 0.0353 |
Diabetes | 2.55 | 0.04 - 586.27 | 0.6789 |
Hypertension | 3.082790e+07 | 0.00 - 5.446095e+113 | 0.9974 |
Cardiovascular disease | 4.05 | 0.01 - 646.67 | 0.5401 |
Aspirin | 0.03 | 0.00 - 2.16 | 0.1346 |
Other antiplatelets | 0.03 | 0.00 - 0.34 | 0.0173 |
Anticoagulants | 0 | NA - Inf | 0.9995 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) | 0 | 0.00 - Inf | 0.9978 |
Aspirin as analgesics | 0 | 0.00 - 0.00 | 0.9996 |
Steroids | 0.59 | 0.02 - 15.27 | 0.7478 |
Selective serotonin reuptake inhibitors (SSRI) | 0 | NA - Inf | 0.9987 |
Proton pump inhibitors (PPI) | 2.21 | 0.10 - 82.65 | 0.6110 |
HMG-CoA inhibitors (statins) | 0 | 0 - 1.858872e+262 | 0.9988 |
Tae Gon Kim
https://orcid.org/0000-0001-6258-6412
Hemodynamic Infarction Associated with Coil Embolization of Intracranial Aneurysm.2003 March;5(1)
Stent-assisted Coil Embolization of Cerebral Aneurysms: Review Article.2011 March;13(1)